Searched for
MULTIPLE MYELOMA DRUG
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Glenmark Pharma hits 10% upper circuit, scales fresh 52-week high on $700 mn cancer drug dealGlenmark Pharma Share Price: Glenmark Pharmaceuticals' shares soared after its subsidiary, Ichnos Glenmark Innovation, inked a global licen...
- Glenmark’s blood cancer drug ISB 2001 shows promising results in trialIchnos Glenmark Innovation's ISB 2001 has shown promising results in treating relapsed or refractory multiple myeloma (RRMM), demonstrating...
- Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drugGlenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated ...
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...
- Lupin launches generic cancer drug in USLupin has launched a generic cancer treatment drug, Doxorubicin Hydrochloride Liposome Injection, in the US market. The product is a generi...
- GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
- Gland Pharma launches generic cancer treatment drug in USThe Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
- Zydus Lifesciences gets USFDA's nod to market generic version of BortezomibThe drug, a generic version of reference listed drug Velcade, will be manufactured at Zydus Hospira, Gujarat.
- Dr Reddy's launches cancer drug in Canada"Our launch of Reddy-Lenalidomide represents our firm commitment to providing access to affordable medicines for Canada's Multiple Myeloma ...
- Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
- Glenmark Pharma begins clinical trial of anti-myeloma drugThe additional study objectives include assessment of biomarkers, immunogenicity and additional measures of anti- tumour activity, it added.
- Glenmark anti-myeloma drug gets clinical trial nod from USFDAThis is Glenmark's second investigational new drug from its immuno-oncology portfolio to enter clinical trials.
- US to import cancer drug,Lipodox, from IndiaThe US said it will import cancer drug manufactured in India to overcome the acute shortage of the medicine used in treatment of ovarian, b...
- Nicholas Piramal to take oncology drug overseas aloneNicholas Piramal plans to take up oncology market on its own for its anti-blood cancer drug.
- NP to conduct clinical trial in US for cancer drugNicholas Piramal to conduct this trial for the first time in the US for its breakthrough blood cancer drug.
- Nicholas Piramal gets FDA okay for cancer drug trialsNicholas Piramal announced on Monday that it had received approval from the USFDA to start clinical trials on humans for its new cancer dru...
Load More
